07/05/2022
WORLD FIRST BREAKTHROUGH | Twenty nine years ago, Dr Carmel Harrington lost her baby, Damien, to Sudden Infant Death Syndrome (SIDS). From then on, she has dedicated her career to researching the condition and finding answers.
Today, she has achieved that goal, identifying the first biochemical marker that indicates a babyโs vulnerability to SIDS while they are still alive.
Together with researchers at our Hospital, Dr Harrington found levels of Butyrylcholinesterase (BChE), an enzyme which plays a major role in the brainโs arousal pathway, were significantly lower in babies who subsequently died of SIDS compared to living controls and other infant deaths.
The findings have the potential to be game-changing, opening up the possibility for intervention and finally giving answers to parents who have lost their children so tragically.
Read more about this groundbreaking study: https://www.schn.health.nsw.gov.au/news/articles/2022/05/world-first-breakthrough-could-prevent-sids
To support Dr Harringtonโs research, visit www.mycause.com.au/p/184401/damiens-legacy